Arcus Investment Limited is authorised and regulated by the Financial Conduct Authority (“FCA”) in the United Kingdom (FRN: 188741) as a Full-scope Alternative Investment Fund Manager (“Full-scope AIFM”) managing open ended Alternative Investment Funds (“AIFs”) and with permissions for segregated investment account business (segregated mandate or separately managed account) under the Markets in Financial Instruments Directive (“MiFID”). Arcus Investment Limited (“AIL”) also acts as the sub-investment manager to Undertakings for the Collective Investment in Transferable Securities (“UCITS”) funds. For U.S. regulatory purposes, Arcus Investment Limited reports to the U.S. Securities and Exchange Commission (“SEC”) as an ‘Exempt Reporting Adviser’ (“ERA”).
Arcus Investment Asia Limited (“AIAL”) (Central Entity No. BDD869) is licensed and regulated by the Securities and Futures Commission (“SFC”) for Type 4 (Advising on securities) and Type 9 (Asset management) Regulated Activities. For U.S. regulatory purposes, Arcus Investment Asia Limited reports to the U.S. Securities and Exchange Commission (“SEC”) as an ‘Exempt Reporting Adviser’ (“ERA”).
Arcus Research Limited, Japan branch (“ARL”) is an Investment Advisory Entity and Representative Agent. Registered No. 471 by the Director General of the Kanto Finance Bureau.
Arcus South East Asia Sdn. Bhd. (“ASEA”) is licensed and regulated by the Securities Commission Malaysia (“SC”) for carrying out the regulated activity of fund management in relation to portfolio management (Licence Number: eCMSL/A0381/2022). For U.S. regulatory purposes, ASEA reports to the U.S. Securities and Exchange Commission (“SEC”) as an ‘Exempt Reporting Adviser’ (“ERA”).
(Collectively, “Arcus”, or “Arcus Group” )